Consultancy
Engaged Intelligence software pilot
Engaged Intelligence writes...on Tuesday 16th January, we started our software pilot. Once we get past the initial test cohort, we will be looking to do a deeper test for willing commercial enterprises in the Cambridge area. Please message us on our LI Page or via the website. ...
From Concept to Compliance: Human Factors and Usability Engineering
Unlock the key to safer and more intuitive medical devices by mastering the application of Human Factors in our exclusive webinar! ...
Selling into the NHS
This two hour market access course is suitable for anyone who is involved in developing new healthcare technologies and products, be it as an entrepreneur, clinician, academic or investor. It will help you to understand key market issues in the UK healthcare market and how to overcome t...
Regulating Medical Devices
Accelerate Your Medical Technology to Market with Expert Regulatory Strategies! Unlock the secrets to swift market entry for your new medical technology by mastering the roadmap to regulatory approval in various markets! Book now to secure your spot and streamline your path to...
Essentials in Health Economics
Explore the fundamental principles of Health Economics and discover how to integrate them seamlessly into the product development cycle. ...
Energy for impact - the antidote to the annual appraisal
Annual appraisals can do more harm than good because they tend to amplify employee dissatisfaction. According to Gallup's latest State of the Global Workplace report, a staggering 90% of UK employees feel disengaged from their employers. ...
Green Leases Breakfast Seminar
Register now for Bidwells' Green Leases bitesize seminar in partnership with Mills & Reeve. ...
Supporting a Phase III R&D strategy within the anti-infective space
Client Issue An emerging pharmaceutical company sought to evaluate Phase III development strategies for an anti-infective drug with potential to treat a range of patient populations. ...
Establishing real-world testing and treatment patterns for EGFR NSCLC patients
Client issue Oncology-focused biotech was looking to establish real-world testing and treatment patterns among EGFR NSCLC patients in US, EU, Japan, and Greater China (mainland, HK, and Taiwan). ...
Rare Disease: 2023 in Review
As we look back at another busy year for the rare disease (RD) space, we also reflect on the continued growth of CRA’s rare disease capabilities and offerings. In the last five years, our consultants have undertaken over 700 client projects in rare diseases, constituting over 20% of our...